The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Prostaglandin E2 Receptor EP4 Subtype Revenue 1.5 Market Analysis by Type 1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 E-7046 1.5.3 ER-886046 1.5.4 grapiprant 1.5.5 KAG-308 1.5.6 ONO-4232 1.5.7 Others 1.6 Market by Application 1.6.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2021-2026 1.6.2 Breast Cancer 1.6.3 Allergies 1.6.4 Chronic Pain 1.6.5 Acute Pain 1.6.6 Lung Cancer 1.6.7 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Prostaglandin E2 Receptor EP4 Subtype Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Prostaglandin E2 Receptor EP4 Subtype Market Players Profiles 3.1 Eisai Co Ltd 3.1.1 Eisai Co Ltd Company Profile 3.1.2 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Ono Pharmaceutical Co Ltd 3.2.1 Ono Pharmaceutical Co Ltd Company Profile 3.2.2 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.2.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Eli Lilly and Co 3.3.1 Eli Lilly and Co Company Profile 3.3.2 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.3.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Kaken Pharmaceutical Co Ltd 3.4.1 Kaken Pharmaceutical Co Ltd Company Profile 3.4.2 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.4.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Rottapharm Biotech Srl 3.5.1 Rottapharm Biotech Srl Company Profile 3.5.2 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.5.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 RaQualia Pharma Inc 3.6.1 RaQualia Pharma Inc Company Profile 3.6.2 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Specification 3.6.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Prostaglandin E2 Receptor EP4 Subtype Market Competition by Market Players 4.1 Global Prostaglandin E2 Receptor EP4 Subtype Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Market Players (2015-2020) 4.3 Global Prostaglandin E2 Receptor EP4 Subtype Average Price by Market Players (2015-2020) 5 Global Prostaglandin E2 Receptor EP4 Subtype Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.1.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in North America (2015-2020) 5.1.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.1.4 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.2.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in East Asia (2015-2020) 5.2.3 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.2.4 East Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.3.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Europe (2015-2020) 5.3.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.3.4 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.4.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in South Asia (2015-2020) 5.4.3 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.4.4 South Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.5.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.5.4 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.6.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Middle East (2015-2020) 5.6.3 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.6.4 Middle East Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.7.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Africa (2015-2020) 5.7.3 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.7.4 Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.8.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Oceania (2015-2020) 5.8.3 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.8.4 Oceania Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.9.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in South America (2015-2020) 5.9.3 South America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.9.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size (2015-2020) 5.10.2 Prostaglandin E2 Receptor EP4 Subtype Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2015-2020) 5.10.4 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2015-2020) 6 Global Prostaglandin E2 Receptor EP4 Subtype Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Consumption by Countries 7 Global Prostaglandin E2 Receptor EP4 Subtype Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype (2021-2026) 7.2 Global Forecasted Revenue of Prostaglandin E2 Receptor EP4 Subtype (2021-2026) 7.3 Global Forecasted Price of Prostaglandin E2 Receptor EP4 Subtype (2021-2026) 7.4 Global Forecasted Production of Prostaglandin E2 Receptor EP4 Subtype by Region (2021-2026) 7.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.3 Europe Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.7 Africa Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.9 South America Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Prostaglandin E2 Receptor EP4 Subtype Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Application (2021-2026) 8 Global Prostaglandin E2 Receptor EP4 Subtype Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.2 East Asia Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.3 Europe Market Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Countriy 8.4 South Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.5 Southeast Asia Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.6 Middle East Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.7 Africa Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.8 Oceania Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.9 South America Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 8.10 Rest of the world Forecasted Consumption of Prostaglandin E2 Receptor EP4 Subtype by Country 9 Global Prostaglandin E2 Receptor EP4 Subtype Sales by Type (2015-2026) 9.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Type (2015-2020) 9.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Type (2021-2026) 10 Global Prostaglandin E2 Receptor EP4 Subtype Consumption by Application (2015-2026) 10.1 Global Prostaglandin E2 Receptor EP4 Subtype Historic Market Size by Application (2015-2020) 10.2 Global Prostaglandin E2 Receptor EP4 Subtype Forecasted Market Size by Application (2021-2026) 11 Global Prostaglandin E2 Receptor EP4 Subtype Manufacturing Cost Analysis 11.1 Prostaglandin E2 Receptor EP4 Subtype Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Prostaglandin E2 Receptor EP4 Subtype 12 Global Prostaglandin E2 Receptor EP4 Subtype Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Prostaglandin E2 Receptor EP4 Subtype Distributors List 12.3 Prostaglandin E2 Receptor EP4 Subtype Customers 12.4 Prostaglandin E2 Receptor EP4 Subtype Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 2,450 | Date : Dec 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 230 |
Price : US$ 2,450 | Date : Nov 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 250 |
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 156 |
Price : US$ 3,500 | Date : Sep 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 148 |
We will be happy to help you find what you need. Please call us or write to us: